Valeant Senior Official Leaves Amid Allergan Takeover Battle - Presented by: The Aol. On Network

An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 17.835 0.17 ▲ 0.93%
SIRI $ 3.95 0.11 ▲ 2.86%
PBR $ 6.445 0.20 ▲ 3.12%
F $ 14.9167 0.37 ▲ 2.52%
FCX $ 12.43 1.06 ▲ 9.32%
ABEV $ 5.47 0.09 ▼ 1.62%
VALE $ 5.27 0.28 ▲ 5.61%
MU $ 19.51 1.39 ▲ 7.67%

As of 7/28/2015, 01:44 PM